GLP-1R Agonist Treatment for Opioid Use Disorder | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
GLP-1R Agonist Treatment for Opioid Use Disorder	Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder	Recruiting	Phase 2	2026-08-28		NCT06548490

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Milton S. Hershey Medical Center	79
National Institute on Drug Abuse (NIDA)	549
New York University	90
Stanley Street Treatment and Resources (SSTAR)	1
University of Maryland	23

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
NYU Langone Health	New York	United States	403
Pennsylvania Psychiatric Institute	Harrisburg	United States	2
Stanley Street Treatment and Resources	Fall River	United States	1
University of Maryland Baltimore	Baltimore	United States	1